Harnessing the Microbiome to Prevent and Treat Malnutrition

Severe acute malnutrition results in nearly 2 million preventable child deaths every year. OpenBiome’s program in Malnutrition is bringing together a coalition of scientists to advance new therapies for this urgent public health threat.

Download Malnutrition Case for Support

Building a world where the full potential of the microbiome radically improves health for all.

45 Million

children under 5 years of age are affected by wasting (defined as low weight-for-height).

149 Million

children under 5 years of age are affected by stunting (defined as low height-for-age).

45%

of childhood deaths under 5 years of age are linked to undernutrition.

The microbiome plays a critical role in the cycle of malnutrition and diarrheal diseases

Healthy nutrition goes beyond food intake. Growth and development also require the right nutrients and an ability to absorb them in the gut. In the last decade, key advances have expanded our understanding of how the microbiome converts food into useful nutrients and helps develop the immune system. Children who suffer malnutrition often lack the microbes capable of maximizing the nutrition available, poorly absorb nutrients, and have an increased risk of infectious diarrhea.

“As a non-profit leading the way in translating microbiome research into patient care, we believe that enhancing childhood malnutrition outcomes could be one of our field’s most significant impacts. With the potential to save thousands of lives annually, we feel an urgent responsibility to apply this science and rigorously evaluate the effectiveness of microbiome-directed interventions.”

– Dr. Majdi Osman, Chief Medical Advisor at OpenBiome

Core Activities

Convening

Bringing together multi-sector experts to deliver a new set of solutions for malnutrition

Research

Advancing the development of novel microbiome-directed products for child nutrition

Trials

Supporting study design and clinical trials of microbiome directed interventions

Training

Sharing know-how and building a scientific network to increase global capacity in microbiome research

Spotlight on THRIVE

OpenBiome’s inaugural global health study, Transfer of Healthy Gut Flora for Restoration of Intestinal Microbiota Via Enema (THRIVE) valuated whether fecal microbiota transplantation (FMT) can help treat children with pediatric Severe Acute Malnutrition (SAM) who have not responded to standard treatment alone.

SAM stunts the growth of 20 million children worldwide, primarily from developing countries, and contributes to 1 million deaths each year.

SAM generally affects children under five years of age.

SAM is a persistent problem in South Africa with 4.5 new cases of SAM per 1000 children.

Over 35% of children with SAM do not respond to the standard treatment of nutrient-enhanced foods and antibiotics.

The THRIVE study is the first to explore broad-spectrum microbiome interventions for the treatment of malnutrition and could catalyze novel therapeutic avenues to address malnutrition.

Collaborators and Funders

THRIVE was supported by the Bill & Melinda Gates Foundation, CRI Foundation, and the Thrasher Research Fund. Enrollment took place at our site partners at the University of Cape Town and Red Cross War Memorial Children’s Hospital in Cape Town, South Africa.